Skip to main content
Top
Published in: BMC Medicine 1/2006

Open Access 01-12-2006 | Research article

Prioritising between direct observation of therapy and case-finding interventions for tuberculosis: use of population impact measures

Authors: Richard F Heller, Islay Gemmell, Richard Edwards, Iain Buchan, Shally Awasthi, James A Volmink

Published in: BMC Medicine | Issue 1/2006

Login to get access

Abstract

Background

Population impact measures (PIMs) have been developed as tools to help policy-makers with locally relevant decisions over health risks and benefits. This involves estimating and prioritising potential benefits of interventions in specific populations. Using tuberculosis (TB) in India as an example, we examined the population impact of two interventions: direct observation of therapy and increasing case-finding.

Methods

PIMs were calculated using published literature and national data for India, and applied to a notional population of 100 000 people. Data included the incidence or prevalence of smear-positive TB and the relative risk reduction from increasing case finding and the use of direct observation of therapy (applied to the baseline risks over the next year), and the incremental proportion of the population eligible for the proposed interventions.

Results

In a population of 100 000 people in India, the directly observed component of the Directly Observed Treatment, Short-course (DOTS) programme may prevent 0.188 deaths from TB in the next year compared with 1.79 deaths by increasing TB case finding. The costs of direct observation are (in international dollars) I$5960 and of case finding are I$4839 or I$31702 and I$2703 per life saved respectively.

Conclusion

Increasing case-finding for TB will save nearly 10 times more lives than will the use of the directly observed component of DOTS in India, at a smaller cost per life saved. The demonstration of the population impact, using simple and explicit numbers, may be of value to policy-makers as they prioritise interventions for their populations.
Literature
1.
go back to reference Heller RF, Dobson AJ: Disease impact number and population impact number: a population perspective to measures of risk and benefit. BMJ. 2000, 321: 950-952. 10.1136/bmj.321.7266.950.CrossRefPubMedPubMedCentral Heller RF, Dobson AJ: Disease impact number and population impact number: a population perspective to measures of risk and benefit. BMJ. 2000, 321: 950-952. 10.1136/bmj.321.7266.950.CrossRefPubMedPubMedCentral
2.
go back to reference Heller RF, Edwards R, McElduff P: Implementing guidelines in primary care: can population impact measures help?. BMC Public Health. 2003, 3: 7-10.1186/1471-2458-3-7.CrossRefPubMedPubMedCentral Heller RF, Edwards R, McElduff P: Implementing guidelines in primary care: can population impact measures help?. BMC Public Health. 2003, 3: 7-10.1186/1471-2458-3-7.CrossRefPubMedPubMedCentral
3.
go back to reference Heller RF, Buchan I, Edwards R, Lyratzopoulos G, McElduff P, St Leger S: Communicating risks at the population level: application of population impact numbers. BMJ. 2003, 327: 1162-1165. 10.1136/bmj.327.7424.1162.CrossRefPubMedPubMedCentral Heller RF, Buchan I, Edwards R, Lyratzopoulos G, McElduff P, St Leger S: Communicating risks at the population level: application of population impact numbers. BMJ. 2003, 327: 1162-1165. 10.1136/bmj.327.7424.1162.CrossRefPubMedPubMedCentral
4.
go back to reference Coker R, Atun R, McKee M: Untangling Gordian knots: improving tuberculosis control through the development of 'programme theories'. Int J Health Plann Manage. 2004, 19: 217-226. 10.1002/hpm.759.CrossRefPubMed Coker R, Atun R, McKee M: Untangling Gordian knots: improving tuberculosis control through the development of 'programme theories'. Int J Health Plann Manage. 2004, 19: 217-226. 10.1002/hpm.759.CrossRefPubMed
5.
go back to reference Volmink J, Matchaba P, Garner P: Directly observed therapy and treatment adherence. Lancet. 2000, 355: 1345-1350. 10.1016/S0140-6736(00)02124-3.CrossRefPubMed Volmink J, Matchaba P, Garner P: Directly observed therapy and treatment adherence. Lancet. 2000, 355: 1345-1350. 10.1016/S0140-6736(00)02124-3.CrossRefPubMed
7.
go back to reference Murray CJ, Salomon JA: Modeling the impact of global tuberculosis control strategies. Proc Natl Acad Sci USA. 1998, 95: 13881-13886. 10.1073/pnas.95.23.13881.CrossRefPubMedPubMedCentral Murray CJ, Salomon JA: Modeling the impact of global tuberculosis control strategies. Proc Natl Acad Sci USA. 1998, 95: 13881-13886. 10.1073/pnas.95.23.13881.CrossRefPubMedPubMedCentral
8.
go back to reference Dye C, Garnett GP, Sleeman K, Williams BG: Prospects for worldwide tuberculosis control under the WHO DOTS strategy. Directly observed short-course therapy. Lancet. 1998, 352: 1886-1891. 10.1016/S0140-6736(98)03199-7.CrossRefPubMed Dye C, Garnett GP, Sleeman K, Williams BG: Prospects for worldwide tuberculosis control under the WHO DOTS strategy. Directly observed short-course therapy. Lancet. 1998, 352: 1886-1891. 10.1016/S0140-6736(98)03199-7.CrossRefPubMed
9.
go back to reference Bleed D, Dye C, Raviglione MC: Dynamics and control of the global tuberculosis epidemic. Curr Opin Pulm Med. 2000, 6: 174-179. 10.1097/00063198-200005000-00002.CrossRefPubMed Bleed D, Dye C, Raviglione MC: Dynamics and control of the global tuberculosis epidemic. Curr Opin Pulm Med. 2000, 6: 174-179. 10.1097/00063198-200005000-00002.CrossRefPubMed
10.
go back to reference Murray CJ, Salomon JA: Expanding the WHO tuberculosis control strategy: rethinking the role of active case-finding. Int J Tuberc Lung Dis. 1998, 2: S9-15.PubMed Murray CJ, Salomon JA: Expanding the WHO tuberculosis control strategy: rethinking the role of active case-finding. Int J Tuberc Lung Dis. 1998, 2: S9-15.PubMed
11.
go back to reference Golub JE, Mohan CI, Comstock GW, Chaisson RE: Active case finding of tuberculosis: historical perspective and future prospects. Int J Tuberc Lung Dis. 2005, 9: 1183-1203.PubMedPubMedCentral Golub JE, Mohan CI, Comstock GW, Chaisson RE: Active case finding of tuberculosis: historical perspective and future prospects. Int J Tuberc Lung Dis. 2005, 9: 1183-1203.PubMedPubMedCentral
12.
go back to reference Volmink J, Garner P: Directly observed therapy for treating tuberculosis. The Cochrane Library. 2003, 1. Volmink J, Garner P: Directly observed therapy for treating tuberculosis. The Cochrane Library. 2003, 1.
13.
go back to reference World Health Organisation: Global Tuberculosis Control: Surveillance, Planning, Financing. 2006, Geneva, Switzerland WHO World Health Organisation: Global Tuberculosis Control: Surveillance, Planning, Financing. 2006, Geneva, Switzerland WHO
14.
go back to reference Baltussen R, Floyd K, Dye C: Cost effectiveness analysis of strategies for tuberculosis control in developing countries. BMJ. 2005, 331: 1364-10.1136/bmj.38645.660093.68.CrossRefPubMedPubMedCentral Baltussen R, Floyd K, Dye C: Cost effectiveness analysis of strategies for tuberculosis control in developing countries. BMJ. 2005, 331: 1364-10.1136/bmj.38645.660093.68.CrossRefPubMedPubMedCentral
16.
go back to reference Jagota P, Mahadev B, Srikantaramu N, Balasangameshwara V, Sreenivas T: Case-finding in diostrict tuberculosis programme: potential and perfromance. Ind J Tub. 1998, 45: 39-46. Jagota P, Mahadev B, Srikantaramu N, Balasangameshwara V, Sreenivas T: Case-finding in diostrict tuberculosis programme: potential and perfromance. Ind J Tub. 1998, 45: 39-46.
17.
go back to reference Fox W, Ellard GA, Mitchison DA: Studies on the treatment of tuberculosis undertaken by the British Medical Research Council Tuberculosis Units, 1946-with relevant subsequent publications. International Journal of Tuberculosis and Lung Disease. 1999, 3: S231-S279.PubMed Fox W, Ellard GA, Mitchison DA: Studies on the treatment of tuberculosis undertaken by the British Medical Research Council Tuberculosis Units, 1946-with relevant subsequent publications. International Journal of Tuberculosis and Lung Disease. 1999, 3: S231-S279.PubMed
18.
go back to reference Dye C, Scheele S, Dolin P, Pathania V, Raviglione MC: Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA. 1999, 282: 677-686. 10.1001/jama.282.7.677.CrossRefPubMed Dye C, Scheele S, Dolin P, Pathania V, Raviglione MC: Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA. 1999, 282: 677-686. 10.1001/jama.282.7.677.CrossRefPubMed
19.
go back to reference Barton S: Clinical Evidence: The International Source of the Best Available Evidence for Effective Health Care. 2004, London: BMJ Publishing Group, 7 Barton S: Clinical Evidence: The International Source of the Best Available Evidence for Effective Health Care. 2004, London: BMJ Publishing Group, 7
20.
go back to reference World Health Organisation: Treatment Of Tuberculosis: Guidelines For Natinal Programmes. WHO/TB/97.220. 1997, Geneva, World Health Organisation World Health Organisation: Treatment Of Tuberculosis: Guidelines For Natinal Programmes. WHO/TB/97.220. 1997, Geneva, World Health Organisation
21.
go back to reference Dye C, Watt CJ, Bleed DM, Williams BG: What is the limit to case detection under the DOTS strategy for tuberculosis control?. Tuberculosis (Edinb). 2003, 83: 35-43. 10.1016/S1472-9792(02)00056-2.CrossRef Dye C, Watt CJ, Bleed DM, Williams BG: What is the limit to case detection under the DOTS strategy for tuberculosis control?. Tuberculosis (Edinb). 2003, 83: 35-43. 10.1016/S1472-9792(02)00056-2.CrossRef
22.
go back to reference Demissie M, Lindtjorn B, Berhane Y: Patient and health service delay in the diagnosis of pulmonary tuberculosis in Ethiopia. BMC Public Health. 2002, 2: 23-10.1186/1471-2458-2-23.CrossRefPubMedPubMedCentral Demissie M, Lindtjorn B, Berhane Y: Patient and health service delay in the diagnosis of pulmonary tuberculosis in Ethiopia. BMC Public Health. 2002, 2: 23-10.1186/1471-2458-2-23.CrossRefPubMedPubMedCentral
23.
go back to reference Volmink J, Garner P: Directly observed therapy for treating tuberculosis. Cochrane Database Syst Rev. 2006, CD003343. Volmink J, Garner P: Directly observed therapy for treating tuberculosis. Cochrane Database Syst Rev. 2006, CD003343.
25.
go back to reference Stone PW, Schackman BR, Neukermans CP, Olchanski N, Greenberg D, Rosen AB, et al: A synthesis of cost-utility analysis literature in infectious disease. Lancet Infect Dis. 2005, 5: 383-391. 10.1016/S1473-3099(05)70142-0.CrossRefPubMed Stone PW, Schackman BR, Neukermans CP, Olchanski N, Greenberg D, Rosen AB, et al: A synthesis of cost-utility analysis literature in infectious disease. Lancet Infect Dis. 2005, 5: 383-391. 10.1016/S1473-3099(05)70142-0.CrossRefPubMed
26.
go back to reference Heller RF, Gemmell I, Wilson EC, Fordham R, Smith RD: Using economic analyses for local priority setting : the population cost-impact approach. Appl Health Econ Health Policy. 2006, 5: 45-54. 10.2165/00148365-200605010-00006.CrossRefPubMed Heller RF, Gemmell I, Wilson EC, Fordham R, Smith RD: Using economic analyses for local priority setting : the population cost-impact approach. Appl Health Econ Health Policy. 2006, 5: 45-54. 10.2165/00148365-200605010-00006.CrossRefPubMed
27.
go back to reference Fahey T, Griffiths S, Peters TJ: Evidence based purchasing: understanding results of clinical trials and systematic reviews. British Medical Journal. 1995, 311: 1056-1059.CrossRefPubMedPubMedCentral Fahey T, Griffiths S, Peters TJ: Evidence based purchasing: understanding results of clinical trials and systematic reviews. British Medical Journal. 1995, 311: 1056-1059.CrossRefPubMedPubMedCentral
28.
go back to reference McGettigan P, Sly K, O'Connell D, Hill S, Henry D: The Effects of Information Framing on the Practices of Physicians. Journal of General Internal Medicine. 1999, 14: 633-642. 10.1046/j.1525-1497.1999.09038.x.CrossRefPubMedPubMedCentral McGettigan P, Sly K, O'Connell D, Hill S, Henry D: The Effects of Information Framing on the Practices of Physicians. Journal of General Internal Medicine. 1999, 14: 633-642. 10.1046/j.1525-1497.1999.09038.x.CrossRefPubMedPubMedCentral
29.
go back to reference Heller RF, Sandars JE, Patterson L, McElduff P: GPs' and physicians' interpretation of risks, benefits and diagnostic test results. Fam Pract. 2004, 21: 155-159. 10.1093/fampra/cmh209.CrossRefPubMed Heller RF, Sandars JE, Patterson L, McElduff P: GPs' and physicians' interpretation of risks, benefits and diagnostic test results. Fam Pract. 2004, 21: 155-159. 10.1093/fampra/cmh209.CrossRefPubMed
30.
go back to reference Dobrow MJ, Goel V, Upshur RE: Evidence-based health policy: context and utilisation. Soc Sci Med. 2004, 58: 207-217. 10.1016/S0277-9536(03)00166-7.CrossRefPubMed Dobrow MJ, Goel V, Upshur RE: Evidence-based health policy: context and utilisation. Soc Sci Med. 2004, 58: 207-217. 10.1016/S0277-9536(03)00166-7.CrossRefPubMed
31.
go back to reference Singer PA, Martin DK, Giacomini M, Purdy L: Priority setting for new technologies in medicine: qualitative case study. BMJ. 2000, 321: 1316-1318. 10.1136/bmj.321.7272.1316.CrossRefPubMedPubMedCentral Singer PA, Martin DK, Giacomini M, Purdy L: Priority setting for new technologies in medicine: qualitative case study. BMJ. 2000, 321: 1316-1318. 10.1136/bmj.321.7272.1316.CrossRefPubMedPubMedCentral
32.
go back to reference Elliott H, Popay J: How are policy makers using evidence? Models of research utilisation and local NHS policy making. J Epidemiol Community Health. 2000, 54: 461-468. 10.1136/jech.54.6.461.CrossRefPubMedPubMedCentral Elliott H, Popay J: How are policy makers using evidence? Models of research utilisation and local NHS policy making. J Epidemiol Community Health. 2000, 54: 461-468. 10.1136/jech.54.6.461.CrossRefPubMedPubMedCentral
Metadata
Title
Prioritising between direct observation of therapy and case-finding interventions for tuberculosis: use of population impact measures
Authors
Richard F Heller
Islay Gemmell
Richard Edwards
Iain Buchan
Shally Awasthi
James A Volmink
Publication date
01-12-2006
Publisher
BioMed Central
Published in
BMC Medicine / Issue 1/2006
Electronic ISSN: 1741-7015
DOI
https://doi.org/10.1186/1741-7015-4-35

Other articles of this Issue 1/2006

BMC Medicine 1/2006 Go to the issue